Ribonucleosides

DBCAT000258Pharmacologic class

Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed). A DrugBank category of 79 drugs. 19 of them are approved.

Drugs: 2-Fluoroadenosine
2'-C-methylcytidine
3-Deazaadenosine
3-Deazacytidine
5-fluorouridine
5-iodotubercidin
5,6-dihydro-5-azacytidine
5'-O-(N-(Alanyl)sulfamoyl)adenosine
7-Methylguanosine
8-Chloroadenosine
8-hydroxy-2'-deoxyguanosine
9-deazainosine
Adafosbuvir
Ademetionine
Adenosine
AMG-319
Azacitidine
Azaribine
AZD-8848
Bentracimab
Binodenoson
Cedazuridine
Cladribine
Cyclouridine
Cytidine
and 54 more with a free account

What you can answer from here — as of August 24, 2016

79DrugsEach linked to its full drug card

128Drug targetsEvery drug–target pair in the class, with bond type

3,308Marketed productsAcross the regions we cover, with dosage forms and routes

13Routes of administrationHow the drugs in this class are given

Which targets do Ribonucleosides share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account